-
1
-
-
0025234906
-
Blood pressure, stroke and coronary heart disease. Part 1: Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
-
1 MacMahon S, Peto R, Cutler J, Collin R, Sorlie P, Neaton J, et al. Blood pressure, stroke and coronary heart disease. Part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
-
(1990)
Lancet
, vol.335
, pp. 765-774
-
-
MacMahon, S.1
Peto, R.2
Cutler, J.3
Collin, R.4
Sorlie, P.5
Neaton, J.6
-
2
-
-
0002938322
-
Hypertension and the risk of cardiovascular disease
-
Laragh JH, Brenner BM (editors): New York: Raven Press
-
2 Kannel WB. Hypertension and the risk of cardiovascular disease. In: Laragh JH, Brenner BM (editors): Hypertension: pathophysiology, diagnosis, and management. New York: Raven Press; 1990. pp. 101-117.
-
(1990)
Hypertension: Pathophysiology, Diagnosis, and Management
, pp. 101-117
-
-
Kannel, W.B.1
-
3
-
-
47649091099
-
A new serum type system in man - The Lp (a) system
-
3 Berg K. A new serum type system in man - the Lp (a) system. Acta Pathol Microbiol Scand 1963; 59:369-382.
-
(1963)
Acta Pathol Microbiol Scand
, vol.59
, pp. 369-382
-
-
Berg, K.1
-
4
-
-
0024362630
-
The mysteries of lipoprotein (a)
-
4 Utermann G. The mysteries of lipoprotein (a). Science 1989; 246:904-910.
-
(1989)
Science
, vol.246
, pp. 904-910
-
-
Utermann, G.1
-
5
-
-
0027333433
-
Cys (4057) of apolipoprotein (a) is essential for lipoprotein (a) assembly
-
5 Brunner C, Kraft HG, Utermann G, Muller HJ. Cys (4057) of apolipoprotein (a) is essential for lipoprotein (a) assembly. Proc Natl Acad Sci USA 1993; 90:11643-11647.
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 11643-11647
-
-
Brunner, C.1
Kraft, H.G.2
Utermann, G.3
Muller, H.J.4
-
6
-
-
0027220885
-
Identification of the cysteine residue in apolipoprotein (a) that mediates extracellular coupling with apolipoprotein B-100
-
6 Koschinsky ML, Cote GP, Gabel B, Van der Hoek YY. Identification of the cysteine residue in apolipoprotein (a) that mediates extracellular coupling with apolipoprotein B-100. J Biol Chem 1993; 268:19819-19825.
-
(1993)
J Biol Chem
, vol.268
, pp. 19819-19825
-
-
Koschinsky, M.L.1
Cote, G.P.2
Gabel, B.3
Van Der Hoek, Y.Y.4
-
7
-
-
0023393811
-
Lp (a) glycoprotein phenotypes: Inheritance and relation to Lp (a)-lipoprotein concentrations in plasma
-
7 Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp (a) glycoprotein phenotypes: inheritance and relation to Lp (a)-lipoprotein concentrations in plasma. J Clin Invest 1987; 80:458-465.
-
(1987)
J Clin Invest
, vol.80
, pp. 458-465
-
-
Utermann, G.1
Menzel, H.J.2
Kraft, H.G.3
Duba, H.C.4
Kemmler, H.G.5
Seitz, C.6
-
8
-
-
0026526357
-
The apolipoprotein (a) gene: A transcribed hypervariable locus controlling plasma lipoprotein (a) concentrations
-
8 Kraft HG, Kochl S, Menzel HJ, Sandholzer C, Utermann G. The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentrations. Hum Genet 1992; 90:220-230.
-
(1992)
Hum Genet
, vol.90
, pp. 220-230
-
-
Kraft, H.G.1
Kochl, S.2
Menzel, H.J.3
Sandholzer, C.4
Utermann, G.5
-
9
-
-
0026667073
-
Apolipoprotein (a) gene accounts for greater than 90% of the variation in plasma lipoprotein (a) concentrations
-
9 Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apolipoprotein (a) gene accounts for greater than 90% of the variation in plasma lipoprotein (a) concentrations. J Clin Invest 1992; 90:52-60.
-
(1992)
J Clin Invest
, vol.90
, pp. 52-60
-
-
Boerwinkle, E.1
Leffert, C.C.2
Lin, J.3
Lackner, C.4
Chiesa, G.5
Hobbs, H.H.6
-
10
-
-
0023689329
-
The apolipoprotein (a) gene resides on human chromosome 6q26-27, in close proximity to the homologous gene for plasminogen
-
10 Frank SL, Klisak I, Sparkes RS. The apolipoprotein (a) gene resides on human chromosome 6q26-27, in close proximity to the homologous gene for plasminogen. Hum Genet 1988; 79:352-356.
-
(1988)
Hum Genet
, vol.79
, pp. 352-356
-
-
Frank, S.L.1
Klisak, I.2
Sparkes, R.S.3
-
11
-
-
0023636242
-
cDNA sequence of human apolipoprotein (a) is homologous to plasminogen
-
11 McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, et al. cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 1987; 330:132-137.
-
(1987)
Nature
, vol.330
, pp. 132-137
-
-
McLean, J.W.1
Tomlinson, J.E.2
Kuang, W.J.3
Eaton, D.L.4
Chen, E.Y.5
Fless, G.M.6
-
12
-
-
0028289634
-
Quantitation of plasma apolipoproteins and the primary and secondary prevention of coronary artery disease
-
12 Rader DJ, Hoeg JM, Brewer HB Jr. Quantitation of plasma apolipoproteins and the primary and secondary prevention of coronary artery disease. Ann Intern Med 1994; 120:1012-1025.
-
(1994)
Ann Intern Med
, vol.120
, pp. 1012-1025
-
-
Rader, D.J.1
Hoeg, J.M.2
Brewer H.B., Jr.3
-
14
-
-
0030958352
-
Association of lipoprotein (a) levels and apolipoprotein (a) size polymorphism with target-organ damage in arterial hypertension
-
14 Sechi LA, Kronenberg F, De Carli S, Falleti E, Zingaro L, Catena C, et al. Association of lipoprotein (a) levels and apolipoprotein (a) size polymorphism with target-organ damage in arterial hypertension. JAMA 1997; 277:1689-1695.
-
(1997)
JAMA
, vol.277
, pp. 1689-1695
-
-
Sechi, L.A.1
Kronenberg, F.2
De Carli, S.3
Falleti, E.4
Zingaro, L.5
Catena, C.6
-
15
-
-
0022485106
-
Haemostatic function and ischemic heart disease: Principal results of the Northwick Park Heart Study
-
15 Meade TW, Mellows S, Brozovic M. Haemostatic function and ischemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2:533-537.
-
(1986)
Lancet
, vol.2
, pp. 533-537
-
-
Meade, T.W.1
Mellows, S.2
Brozovic, M.3
-
17
-
-
0027212213
-
Blood viscosity, fibrinogen and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study
-
17 Lowe GD, Fowkes FG, Dawes J, Donnan PT, Lennie SE, Housley E. Blood viscosity, fibrinogen and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 1993; 87:1915-1920.
-
(1993)
Circulation
, vol.87
, pp. 1915-1920
-
-
Lowe, G.D.1
Fowkes, F.G.2
Dawes, J.3
Donnan, P.T.4
Lennie, S.E.5
Housley, E.6
-
18
-
-
0020045862
-
Detection and relevance of cross linked fibrin derivatives in blood
-
18 Graeff H, Hafter R. Detection and relevance of cross linked fibrin derivatives in blood. Semin Thromb Haemost 1982; 8:57-68.
-
(1982)
Semin Thromb Haemost
, vol.8
, pp. 57-68
-
-
Graeff, H.1
Hafter, R.2
-
19
-
-
0028126597
-
Plasma concentrations of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men
-
19 Ridker PM, Hennekens CH, Cerskus A, Stampfer MJ. Plasma concentrations of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation 1994; 90:2236-2240.
-
(1994)
Circulation
, vol.90
, pp. 2236-2240
-
-
Ridker, P.M.1
Hennekens, C.H.2
Cerskus, A.3
Stampfer, M.J.4
-
20
-
-
0031445511
-
Hemostatic factors as predictors of ischemic heart disease and stroke in the Edimburgh Artery Study
-
20 Smith FB, Lee AJ, Fowkes FG, Price JF, Rumley A, Lowe GD. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edimburgh Artery Study. Arterioscler Thromb Vasc Biol 1997; 17:3321-3325.
-
(1997)
Arterioscler Thromb Vasc Biol
, vol.17
, pp. 3321-3325
-
-
Smith, F.B.1
Lee, A.J.2
Fowkes, F.G.3
Price, J.F.4
Rumley, A.5
Lowe, G.D.6
-
21
-
-
0027160374
-
Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease
-
21 Fowkes FG, Lowe GD, Housley E, Rattray A, Rumley A, Elton RA. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet 1993; 342:84-86.
-
(1993)
Lancet
, vol.342
, pp. 84-86
-
-
Fowkes, F.G.1
Lowe, G.D.2
Housley, E.3
Rattray, A.4
Rumley, A.5
Elton, R.A.6
-
22
-
-
0024539832
-
Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis
-
22 Hajjar KA, Gavish D, Breslow JL, Nachman RL. Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989; 339:303-305.
-
(1989)
Nature
, vol.339
, pp. 303-305
-
-
Hajjar, K.A.1
Gavish, D.2
Breslow, J.L.3
Nachman, R.L.4
-
23
-
-
0024554547
-
A potential basis for the thrombotic risk associated with lipoprotein (a)
-
23 Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. A potential basis for the thrombotic risk associated with lipoprotein (a). Nature 1989; 339:301-303.
-
(1989)
Nature
, vol.339
, pp. 301-303
-
-
Miles, L.A.1
Fless, G.M.2
Levin, E.G.3
Scanu, A.M.4
Plow, E.F.5
-
24
-
-
0024456833
-
Detection and quantitation of lipoprotein (a) in the arterial wall of 107 coronary bypass patients
-
24 Rath M, Niendorf A, Reblin T, Dietel M, Kreber HJ, Beisiegel U. Detection and quantitation of lipoprotein (a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis 1989; 9:579-592.
-
(1989)
Arteriosclerosis
, vol.9
, pp. 579-592
-
-
Rath, M.1
Niendorf, A.2
Reblin, T.3
Dietel, M.4
Kreber, H.J.5
Beisiegel, U.6
-
26
-
-
0030096955
-
Standardization of methods of lipid determination according to WHO in the regional project of prevention of cardiovascular diseases in Friuli-Venezia Giulia
-
26 Grafnetter D, Feruglio GA, Vanuzzo D. Standardization of methods of lipid determination according to WHO in the regional project of prevention of cardiovascular diseases in Friuli-Venezia Giulia. G Ital Cardiol 1996; 26:287-297.
-
(1996)
G Ital Cardiol
, vol.26
, pp. 287-297
-
-
Grafnetter, D.1
Feruglio, G.A.2
Vanuzzo, D.3
-
27
-
-
0026446761
-
Insulin hypersecretion: A distinctive feature between essential and secondary hypertension
-
27 Sechi LA, Melis A, Tedde R. Insulin hypersecretion: a distinctive feature between essential and secondary hypertension. Metabolism 1992; 11:1261-1266.
-
(1992)
Metabolism
, vol.11
, pp. 1261-1266
-
-
Sechi, L.A.1
Melis, A.2
Tedde, R.3
-
28
-
-
0015348189
-
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative centrifuge
-
28 Friedewald WT, Levy RI, Friedrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative centrifuge. Clin Chem 1972; 18:499-502.
-
(1972)
Clin Chem
, vol.18
, pp. 499-502
-
-
Friedewald, W.T.1
Levy, R.I.2
Friedrickson, D.S.3
-
29
-
-
0024253705
-
Method for determination of functional (clottable) fibrinogen by the new family of ACL coagulometers
-
29 Rossi E, Lombardi A, Preda L. Method for determination of functional (clottable) fibrinogen by the new family of ACL coagulometers. Thromb Res 1988; 52:453-468.
-
(1988)
Thromb Res
, vol.52
, pp. 453-468
-
-
Rossi, E.1
Lombardi, A.2
Preda, L.3
-
30
-
-
0026071629
-
Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide
-
30 Pelzer H, Schwarz A, Stuber W. Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemost 1991; 65:153-159.
-
(1991)
Thromb Haemost
, vol.65
, pp. 153-159
-
-
Pelzer, H.1
Schwarz, A.2
Stuber, W.3
-
31
-
-
0021084637
-
An immunoassay for human D-dimer using monoclonal antibodies
-
31 Rylatt DB, Blake AS, Cottis LE, Massingham DA, Fletcher WA, Masci PP, et al. An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 1983; 31:767-778.
-
(1983)
Thromb Res
, vol.31
, pp. 767-778
-
-
Rylatt, D.B.1
Blake, A.S.2
Cottis, L.E.3
Massingham, D.A.4
Fletcher, W.A.5
Masci, P.P.6
-
32
-
-
0032531112
-
Increased serum lipoprotein (a) levels in patients with early renal failure
-
32 Sechi LA, Zingaro L, De Carli S, Sechi G, Catena C, Falleti E, et al. Increased serum lipoprotein (a) levels in patients with early renal failure. Ann Intern Med 1998; 129:457-461.
-
(1998)
Ann Intern Med
, vol.129
, pp. 457-461
-
-
Sechi, L.A.1
Zingaro, L.2
De Carli, S.3
Sechi, G.4
Catena, C.5
Falleti, E.6
-
33
-
-
0029101292
-
Multicenter study of lipoprotein (a) and apolipoprotein (a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis
-
33 Kronenberg F, Konig P, Neyer U, Auinger M, Pribasnig A, Lang U, et al. Multicenter study of lipoprotein (a) and apolipoprotein (a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1995; 6:110-120.
-
(1995)
J Am Soc Nephrol
, vol.6
, pp. 110-120
-
-
Kronenberg, F.1
Konig, P.2
Neyer, U.3
Auinger, M.4
Pribasnig, A.5
Lang, U.6
-
34
-
-
0026631199
-
Significant association between low-molecular-weight apolipoprotein (a) isoforms and intermittent claudication
-
34 Molgaard J, Klausen IC, Lassvik C, Faergeman O, Gerdes LU, Olsson AG. Significant association between low-molecular-weight apolipoprotein (a) isoforms and intermittent claudication. Arterioscler Thromb 1992; 12: 895-901.
-
(1992)
Arterioscler Thromb
, vol.12
, pp. 895-901
-
-
Molgaard, J.1
Klausen, I.C.2
Lassvik, C.3
Faergeman, O.4
Gerdes, L.U.5
Olsson, A.G.6
-
35
-
-
0022515518
-
Associations of levels of lipoprotein (a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography
-
35 Dahlen G, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM Jr. Associations of levels of lipoprotein (a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74:758-765.
-
(1986)
Circulation
, vol.74
, pp. 758-765
-
-
Dahlen, G.1
Guyton, J.R.2
Attar, M.3
Farmer, J.A.4
Kautz, J.A.5
Gotto A.M., Jr.6
-
36
-
-
0029740582
-
Elevated plasma lipoprotein (a) and coronary heart disease in men aged 55 years and younger. A prospective study
-
36 Bostom AG, Cupples LA, Jenner JL, Ordovas JM, Seman LJ, Wilson PWF, et al. Elevated plasma lipoprotein (a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA 1996; 276:544-548.
-
(1996)
JAMA
, vol.276
, pp. 544-548
-
-
Bostom, A.G.1
Cupples, L.A.2
Jenner, J.L.3
Ordovas, J.M.4
Seman, L.J.5
Wilson, P.W.F.6
-
37
-
-
0031729386
-
Lipoprotein (a) as a risk factor for ischemic heart disease: Meta-analysis of prospective studies
-
37 Craig WY, Neveux LM, Palomaki GE, Cleveland MM, Haddow JE. Lipoprotein (a) as a risk factor for ischemic heart disease: meta-analysis of prospective studies. Clin Chem 1998; 44:2301-2306.
-
(1998)
Clin Chem
, vol.44
, pp. 2301-2306
-
-
Craig, W.Y.1
Neveux, L.M.2
Palomaki, G.E.3
Cleveland, M.M.4
Haddow, J.E.5
-
38
-
-
0022546653
-
Lipoprotein (a) as a strong indicator for cerebrovascular disease
-
38 Zenker G, Koltringer P, Bone G, Niederkorn K, Pfeiffer K, Jurgens G. Lipoprotein (a) as a strong indicator for cerebrovascular disease. Stroke 1986; 17:942-945.
-
(1986)
Stroke
, vol.17
, pp. 942-945
-
-
Zenker, G.1
Koltringer, P.2
Bone, G.3
Niederkorn, K.4
Pfeiffer, K.5
Jurgens, G.6
-
39
-
-
0027175071
-
High serum lipoprotein (a) levels are an independent risk factor for cerebral infarction
-
39 Shintani S, Kikuchi S, Hamaguchi H, Shiigai T. High serum lipoprotein (a) levels are an independent risk factor for cerebral infarction. Stroke 1993; 24:965-969.
-
(1993)
Stroke
, vol.24
, pp. 965-969
-
-
Shintani, S.1
Kikuchi, S.2
Hamaguchi, H.3
Shiigai, T.4
-
40
-
-
0027516698
-
Lipoprotein (a), low-density, intermediate-density lipoprotein, and blood pressure in a young male population
-
40 Steinmetz A, Kirklies A, Schlosser G, Cassel W, Peter JH, Ehlenz K, et al. Lipoprotein (a), low-density, intermediate-density lipoprotein, and blood pressure in a young male population. Clin Invest 1993; 71:145-149.
-
(1993)
Clin Invest
, vol.71
, pp. 145-149
-
-
Steinmetz, A.1
Kirklies, A.2
Schlosser, G.3
Cassel, W.4
Peter, J.H.5
Ehlenz, K.6
-
41
-
-
0028589292
-
Plasma lipids and lipoproteins and essential hypertension
-
41 Flesch M, Sachinidis A, Ko YD, Kraft K, Vetter H. Plasma lipids and lipoproteins and essential hypertension. Clin Invest 1994; 72:944-950.
-
(1994)
Clin Invest
, vol.72
, pp. 944-950
-
-
Flesch, M.1
Sachinidis, A.2
Ko, Y.D.3
Kraft, K.4
Vetter, H.5
-
42
-
-
0025311925
-
Lipoprotein (a). Heterogeneity and biological relevance
-
42 Scanu AM, Fless GM. Lipoprotein (a). Heterogeneity and biological relevance. J Clin Invest 1990; 85:1709-1715.
-
(1990)
J Clin Invest
, vol.85
, pp. 1709-1715
-
-
Scanu, A.M.1
Fless, G.M.2
-
43
-
-
0024427366
-
Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a north Swedish population
-
43 Sundell IB, Nilsson TK, Hallmans G, Hellsten G, Dahlen GH. Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a north Swedish population. Atherosclerosis 1989; 80:9-16.
-
(1989)
Atherosclerosis
, vol.80
, pp. 9-16
-
-
Sundell, I.B.1
Nilsson, T.K.2
Hallmans, G.3
Hellsten, G.4
Dahlen, G.H.5
-
44
-
-
0025332320
-
The increased plasma Lp (a): B lipoprotein particle concentration in angina pectoris is not associated with hypofibrinolysis
-
44 Alessi MC, Parra HJ, Joly P, Vu-Dac N, Bard JM, Fruchart JC, et al. The increased plasma Lp (a): B lipoprotein particle concentration in angina pectoris is not associated with hypofibrinolysis. Clin Chim Acta 1990; 188:119-127.
-
(1990)
Clin Chim Acta
, vol.188
, pp. 119-127
-
-
Alessi, M.C.1
Parra, H.J.2
Joly, P.3
Vu-Dac, N.4
Bard, J.M.5
Fruchart, J.C.6
-
45
-
-
0025800312
-
Fibrinolytic parameters and lipoprotein (a) levels in plasma of patients with coronary artery disease
-
45 Garcia Frade LJ, Alvarez JJ, Rayo I, Torrado MC, Lasuncion MA, Garcia Avello A, et al. Fibrinolytic parameters and lipoprotein (a) levels in plasma of patients with coronary artery disease. Thromb Res 1991; 63:407-418.
-
(1991)
Thromb Res
, vol.63
, pp. 407-418
-
-
Garcia Frade, L.J.1
Alvarez, J.J.2
Rayo, I.3
Torrado, M.C.4
Lasuncion, M.A.5
Garcia Avello, A.6
-
46
-
-
0026355887
-
Relationship of lipoprotein (a) to variables of coagulation and fibrinolysis in a healthy population
-
46 Heinrich J, Sandkamp M, Kokott R, Schulte H, Assman G. Relationship of lipoprotein (a) to variables of coagulation and fibrinolysis in a healthy population. Clin Chem 1991; 37:1950-1954.
-
(1991)
Clin Chem
, vol.37
, pp. 1950-1954
-
-
Heinrich, J.1
Sandkamp, M.2
Kokott, R.3
Schulte, H.4
Assman, G.5
-
47
-
-
0027939971
-
Concentrations of Lp (a) in black and white young adults: Relations to risk factors for cardiovascular disease
-
47 Howard BV, Le NA, Belcher JD, Flack JM, Jacobs DR Jr, Lewis CE, et al. Concentrations of Lp (a) in black and white young adults: relations to risk factors for cardiovascular disease. Ann Epidemiol 1994; 4:341-350.
-
(1994)
Ann Epidemiol
, vol.4
, pp. 341-350
-
-
Howard, B.V.1
Le, N.A.2
Belcher, J.D.3
Flack, J.M.4
Jacobs D.R., Jr.5
Lewis, C.E.6
-
48
-
-
0028922686
-
Lipoprotein (a) levels in the Japanese population: Influence of age and sex, and relation to atherosclerotic risk factors. The Jichi Medical School Cohort Study
-
48 Nago N, Kayaba K, Hiraoka J, Matsuo H, Goto T, Kario K, et al. Lipoprotein (a) levels in the Japanese population: influence of age and sex, and relation to atherosclerotic risk factors. The Jichi Medical School Cohort Study. Am J Epidemiol 1995; 141:815-821.
-
(1995)
Am J Epidemiol
, vol.141
, pp. 815-821
-
-
Nago, N.1
Kayaba, K.2
Hiraoka, J.3
Matsuo, H.4
Goto, T.5
Kario, K.6
-
49
-
-
0030712956
-
Haemostasis balance disorders in patients with essential hypertension
-
49 Makris TK, Tsoukala C, Krespi P, Hatzizacharias A, Gialeraki A, Papargyriou J, et al. Haemostasis balance disorders in patients with essential hypertension. Thromb Res 1997; 88:99-107.
-
(1997)
Thromb Res
, vol.88
, pp. 99-107
-
-
Makris, T.K.1
Tsoukala, C.2
Krespi, P.3
Hatzizacharias, A.4
Gialeraki, A.5
Papargyriou, J.6
-
50
-
-
0028490519
-
Fibrinogen levels in normotensive and hypertensive men: A cross-sectional study
-
50 Fogari R, Zoppi A, Tettamanti F, Malamani GD, Marasi G, Vanasia A, et al. Fibrinogen levels in normotensive and hypertensive men: a cross-sectional study. J Cardiovasc Risk 1994; 1:149-153.
-
(1994)
J Cardiovasc Risk
, vol.1
, pp. 149-153
-
-
Fogari, R.1
Zoppi, A.2
Tettamanti, F.3
Malamani, G.D.4
Marasi, G.5
Vanasia, A.6
-
51
-
-
0031449649
-
Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy
-
51 Lip GY, Blann AD, Jones AF, Lip PL, Beevers DG. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. Am J Cardiol 1997; 80:1566-1571.
-
(1997)
Am J Cardiol
, vol.80
, pp. 1566-1571
-
-
Lip, G.Y.1
Blann, A.D.2
Jones, A.F.3
Lip, P.L.4
Beevers, D.G.5
-
52
-
-
0027645770
-
Coagulation and inhibitory and fibrinolytic proteins in essential hypertension
-
52 Vaziri ND, Smith DHG, Winer RL, Weber MA, Gonzales EC, Neutel JM. Coagulation and inhibitory and fibrinolytic proteins in essential hypertension. J Am Soc Nephrol 1993; 4:222-228.
-
(1993)
J Am Soc Nephrol
, vol.4
, pp. 222-228
-
-
Vaziri, N.D.1
Smith, D.H.G.2
Winer, R.L.3
Weber, M.A.4
Gonzales, E.C.5
Neutel, J.M.6
-
53
-
-
0026648788
-
Lipoprotein (a) in woman twins: Heritability and relationship to apolipoprotein (a) phenotypes
-
53 Austin MA, Sandholzer C, Selby JV, Newman B, Krauss RM, Utermann G. Lipoprotein (a) in woman twins: heritability and relationship to apolipoprotein (a) phenotypes. Am J Hum Genet 1992; 51:829-840.
-
(1992)
Am J Hum Genet
, vol.51
, pp. 829-840
-
-
Austin, M.A.1
Sandholzer, C.2
Selby, J.V.3
Newman, B.4
Krauss, R.M.5
Utermann, G.6
-
54
-
-
0027503266
-
Effects of age, sex, and menopausal status on plasma lipoprotein (a) levels: The Framingham Offspring Study
-
54 Jenner JL, Ordovas JM, Lamon-Fava S. Effects of age, sex, and menopausal status on plasma lipoprotein (a) levels: the Framingham Offspring Study. Circulation 1993; 87:1135-1141.
-
(1993)
Circulation
, vol.87
, pp. 1135-1141
-
-
Jenner, J.L.1
Ordovas, J.M.2
Lamon-Fava, S.3
|